Increased risk of attention-deficit/hyperactivity disorder associated with exposure to organophosphate pesticide in Taiwanese children

C. J. Yu, J. C. Du, H. C. Chiou, M. Y. Chung, W. Yang, Y. S. Chen, M. R. Fuh, L. C. Chien, B. Hwang, M. L. Chen

研究成果: 雜誌貢獻文章

23 引文 (Scopus)

摘要

Attention-deficit/hyperactivity disorder (ADHD) is male predominated, and the etiology of this disorder remains unclear. Past studies have assessed the association of low-level organophosphate pesticide exposure with childhood ADHD cross-sectionally and prospectively. However, the results have been inconsistent. A first case–control study was performed to investigate the relationship between organophosphate pesticide exposure and ADHD with adjusted covariates. We recruited 97 doctor-diagnosed ADHD cases and 110 non-ADHD controls who were 4–15 years of age. Exposure was assessed using urinary levels of dialkylphosphate metabolites, which are biomarkers of OP pesticide exposure. Blood lead levels and polymorphisms of two commonly verified dopaminergic-related genes (the D4 dopamine receptor gene DRD4 and the dopamine transporter gene DAT1) were also analyzed. The sociodemographics and lifestyles of the children and of the mothers during pregnancy were collected using a questionnaire. The blood lead levels of both groups were similar (1.57 ± 0.73 vs. 1.73 ± 0.77 μg/dL, p = 0.15). Significant urinary concentration differences in one of the six dialkylphosphate metabolites, dimethylphosphate (DMP), were found between ADHD and control subjects (322.92 ± 315.68 vs. 224.37 ± 156.58 nmol/g cr., p < 0.01). A dose–response relationship was found between urinary concentrations of DMP and ADHD in both crude and adjusted analyses (p for trend<0.05). Children with higher urinary DMP concentrations may have a twofold to threefold increased risk of being diagnosed with ADHD. We report a dose–response relationship between child DMP levels and ADHD. Organophosphate pesticide exposure may have deleterious effects on children's neurodevelopment, particularly the development of ADHD.
原文英語
頁(從 - 到)695-705
頁數11
期刊Andrology
4
發行號4
DOIs
出版狀態已發佈 - 七月 1 2016

指紋

Organophosphates
Attention Deficit Disorder with Hyperactivity
Pesticides
Dopamine D4 Receptors
Genes
Dopamine Plasma Membrane Transport Proteins
Life Style
Biomarkers
Mothers
Pregnancy
dimethyl phosphate

ASJC Scopus subject areas

  • Endocrinology, Diabetes and Metabolism
  • Reproductive Medicine
  • Endocrinology
  • Urology

引用此文

Increased risk of attention-deficit/hyperactivity disorder associated with exposure to organophosphate pesticide in Taiwanese children. / Yu, C. J.; Du, J. C.; Chiou, H. C.; Chung, M. Y.; Yang, W.; Chen, Y. S.; Fuh, M. R.; Chien, L. C.; Hwang, B.; Chen, M. L.

於: Andrology, 卷 4, 編號 4, 01.07.2016, p. 695-705.

研究成果: 雜誌貢獻文章

Yu, CJ, Du, JC, Chiou, HC, Chung, MY, Yang, W, Chen, YS, Fuh, MR, Chien, LC, Hwang, B & Chen, ML 2016, 'Increased risk of attention-deficit/hyperactivity disorder associated with exposure to organophosphate pesticide in Taiwanese children', Andrology, 卷 4, 編號 4, 頁 695-705. https://doi.org/10.1111/andr.12183
Yu, C. J. ; Du, J. C. ; Chiou, H. C. ; Chung, M. Y. ; Yang, W. ; Chen, Y. S. ; Fuh, M. R. ; Chien, L. C. ; Hwang, B. ; Chen, M. L. / Increased risk of attention-deficit/hyperactivity disorder associated with exposure to organophosphate pesticide in Taiwanese children. 於: Andrology. 2016 ; 卷 4, 編號 4. 頁 695-705.
@article{d9cdd9bbd6b3436aa542c216c4a8ba6f,
title = "Increased risk of attention-deficit/hyperactivity disorder associated with exposure to organophosphate pesticide in Taiwanese children",
abstract = "Attention-deficit/hyperactivity disorder (ADHD) is male predominated, and the etiology of this disorder remains unclear. Past studies have assessed the association of low-level organophosphate pesticide exposure with childhood ADHD cross-sectionally and prospectively. However, the results have been inconsistent. A first case–control study was performed to investigate the relationship between organophosphate pesticide exposure and ADHD with adjusted covariates. We recruited 97 doctor-diagnosed ADHD cases and 110 non-ADHD controls who were 4–15 years of age. Exposure was assessed using urinary levels of dialkylphosphate metabolites, which are biomarkers of OP pesticide exposure. Blood lead levels and polymorphisms of two commonly verified dopaminergic-related genes (the D4 dopamine receptor gene DRD4 and the dopamine transporter gene DAT1) were also analyzed. The sociodemographics and lifestyles of the children and of the mothers during pregnancy were collected using a questionnaire. The blood lead levels of both groups were similar (1.57 ± 0.73 vs. 1.73 ± 0.77 μg/dL, p = 0.15). Significant urinary concentration differences in one of the six dialkylphosphate metabolites, dimethylphosphate (DMP), were found between ADHD and control subjects (322.92 ± 315.68 vs. 224.37 ± 156.58 nmol/g cr., p < 0.01). A dose–response relationship was found between urinary concentrations of DMP and ADHD in both crude and adjusted analyses (p for trend<0.05). Children with higher urinary DMP concentrations may have a twofold to threefold increased risk of being diagnosed with ADHD. We report a dose–response relationship between child DMP levels and ADHD. Organophosphate pesticide exposure may have deleterious effects on children's neurodevelopment, particularly the development of ADHD.",
keywords = "ADHD, blood lead levels, dialkylphosphate metabolites, gene polymorphism, organophosphate pesticides",
author = "Yu, {C. J.} and Du, {J. C.} and Chiou, {H. C.} and Chung, {M. Y.} and W. Yang and Chen, {Y. S.} and Fuh, {M. R.} and Chien, {L. C.} and B. Hwang and Chen, {M. L.}",
year = "2016",
month = "7",
day = "1",
doi = "10.1111/andr.12183",
language = "English",
volume = "4",
pages = "695--705",
journal = "Andrology",
issn = "2047-2919",
publisher = "Wiley-Blackwell Publishing Ltd",
number = "4",

}

TY - JOUR

T1 - Increased risk of attention-deficit/hyperactivity disorder associated with exposure to organophosphate pesticide in Taiwanese children

AU - Yu, C. J.

AU - Du, J. C.

AU - Chiou, H. C.

AU - Chung, M. Y.

AU - Yang, W.

AU - Chen, Y. S.

AU - Fuh, M. R.

AU - Chien, L. C.

AU - Hwang, B.

AU - Chen, M. L.

PY - 2016/7/1

Y1 - 2016/7/1

N2 - Attention-deficit/hyperactivity disorder (ADHD) is male predominated, and the etiology of this disorder remains unclear. Past studies have assessed the association of low-level organophosphate pesticide exposure with childhood ADHD cross-sectionally and prospectively. However, the results have been inconsistent. A first case–control study was performed to investigate the relationship between organophosphate pesticide exposure and ADHD with adjusted covariates. We recruited 97 doctor-diagnosed ADHD cases and 110 non-ADHD controls who were 4–15 years of age. Exposure was assessed using urinary levels of dialkylphosphate metabolites, which are biomarkers of OP pesticide exposure. Blood lead levels and polymorphisms of two commonly verified dopaminergic-related genes (the D4 dopamine receptor gene DRD4 and the dopamine transporter gene DAT1) were also analyzed. The sociodemographics and lifestyles of the children and of the mothers during pregnancy were collected using a questionnaire. The blood lead levels of both groups were similar (1.57 ± 0.73 vs. 1.73 ± 0.77 μg/dL, p = 0.15). Significant urinary concentration differences in one of the six dialkylphosphate metabolites, dimethylphosphate (DMP), were found between ADHD and control subjects (322.92 ± 315.68 vs. 224.37 ± 156.58 nmol/g cr., p < 0.01). A dose–response relationship was found between urinary concentrations of DMP and ADHD in both crude and adjusted analyses (p for trend<0.05). Children with higher urinary DMP concentrations may have a twofold to threefold increased risk of being diagnosed with ADHD. We report a dose–response relationship between child DMP levels and ADHD. Organophosphate pesticide exposure may have deleterious effects on children's neurodevelopment, particularly the development of ADHD.

AB - Attention-deficit/hyperactivity disorder (ADHD) is male predominated, and the etiology of this disorder remains unclear. Past studies have assessed the association of low-level organophosphate pesticide exposure with childhood ADHD cross-sectionally and prospectively. However, the results have been inconsistent. A first case–control study was performed to investigate the relationship between organophosphate pesticide exposure and ADHD with adjusted covariates. We recruited 97 doctor-diagnosed ADHD cases and 110 non-ADHD controls who were 4–15 years of age. Exposure was assessed using urinary levels of dialkylphosphate metabolites, which are biomarkers of OP pesticide exposure. Blood lead levels and polymorphisms of two commonly verified dopaminergic-related genes (the D4 dopamine receptor gene DRD4 and the dopamine transporter gene DAT1) were also analyzed. The sociodemographics and lifestyles of the children and of the mothers during pregnancy were collected using a questionnaire. The blood lead levels of both groups were similar (1.57 ± 0.73 vs. 1.73 ± 0.77 μg/dL, p = 0.15). Significant urinary concentration differences in one of the six dialkylphosphate metabolites, dimethylphosphate (DMP), were found between ADHD and control subjects (322.92 ± 315.68 vs. 224.37 ± 156.58 nmol/g cr., p < 0.01). A dose–response relationship was found between urinary concentrations of DMP and ADHD in both crude and adjusted analyses (p for trend<0.05). Children with higher urinary DMP concentrations may have a twofold to threefold increased risk of being diagnosed with ADHD. We report a dose–response relationship between child DMP levels and ADHD. Organophosphate pesticide exposure may have deleterious effects on children's neurodevelopment, particularly the development of ADHD.

KW - ADHD

KW - blood lead levels

KW - dialkylphosphate metabolites

KW - gene polymorphism

KW - organophosphate pesticides

UR - http://www.scopus.com/inward/record.url?scp=84979645624&partnerID=8YFLogxK

UR - http://www.scopus.com/inward/citedby.url?scp=84979645624&partnerID=8YFLogxK

U2 - 10.1111/andr.12183

DO - 10.1111/andr.12183

M3 - Article

C2 - 27070915

AN - SCOPUS:84979645624

VL - 4

SP - 695

EP - 705

JO - Andrology

JF - Andrology

SN - 2047-2919

IS - 4

ER -